Effects of the Genetic Polymorphisms on Urinary Excretion of 1-Hydroxypyrene and 2-Naphthol

일반인구에서 유전자 다형성이 요중 1-hydroxypyrene 및 2-naphthol의 배설량에 미치는 영향

  • Published : 2005.05.01


This study was performed to determine the effects of genetic polymorphisms, such as glutathione S-transferase ${\mu}1(GSTM1)$, glutathione S-transferase ${\Theta}1\;(GSTM1)$, glutathione S-transferase ${\pi}l (GSTP1)$, aryl hydrocarbon N-acetyltransferase 2 (NAT2), cytochrome P450 2E1 (CYP2E1), cytochrome P450 1A1 (CYP1A1) on the concentrations of urinary 1-hydroxypyrene (1-OHP) and 2-naphthol in general population with no occupational exposure to polycyclic aromatic hydrocarbons (PAHs). Study subjects were 257 men who visited a health promotion center in Susan. A questionnaire was used to obtain detailed data about age, smoking, drinking, body fat mass, intake of fat etc. Urinary l-OHP and 2-naphthol concentration were analyzed by HPLC system with a fluorescence detector. A multiplex PCR method was used to identify the genotypes for GSTM1 and GSTT1. The polymorphisms of GSTP1, NAT2, CYP1A1 and CYP2E1 were determined by the polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) method. Urinary 1-OHP concentration was higher in deleted genotype of GSTM1, increased as smoking and alcohol drinking increased. Urinary 2-naphthol concentration was also rely on the age and smoking. Neither genetic polymorphism nor drinking-related factors were significantly related to urinary 2-naphthol concentration. No significant relation was found between physical characteristics and concentrations of urinary PAHs metabolites in the subjects, but the geometric mean of urinary 1-OHP and 2-naphthol was higher in the group with higher value compared to median value. These data suggest that in general population occupationally not exposed to PAHs, urinary concentration of PAHs metabolites is influenced by smoking, alcohol drinking and deleted genotype of GSTM1 in 1-OHP and smoking in 2-naphthol.


PAHs;Genetic polymorphisms;1-OHP;2-Naphthol;HPLC;PCR;Smoking


  1. Hemminki, K., 1990, Environmental carcinogens. m: Cooper CS, Crover RL(eds) chemical carcinogenesis and mutagenesis, Raven Press, New York, U.S.A., (I), 33-62pp
  2. Wise, S. A., B. A. Benner, H. C. Liu, G. D. Byrd and A. Colmsjo, 1988, Seperation and identification of polycyclic aromatic hydrocarbon isomers of molecular weight 302 in complex mixtures, Anal. Chem., 60(7), 630-637
  3. Singh, R., M. Tucek, K. Maxa, J. Tenglerova and E. H. Weyand, Hili, A rapid and simple method for the analysis of 1-hydroxypyrene glucuronide: a potential biomarker for polycyclic aromatic hydrocarbon exposure, Carcinogenesis, 16(12), 2909-2915
  4. Tingle, M. D., M. Primohemed, E. Templeton, A. S. Wilson and S. Madden, 1993, An investigation of the formation of cytotoxic, geno-toxic, protein-reactive and stable metabolites from naphthalene by human liver microsomes, Biochem. Pharmacol., 46, 1529-1538
  5. Nerbert, D. W. and F. J. Gonzalez, 1987, P450 gene: structure, evaluation and. regulation, Ann. Rev. Biochem., 56, 945-993
  6. Ayesh, R., J. R. Idle, J. C. Ritchie, M. R. Crothers and M. J. Hetzel, 1984, Metabolic oxidation phenotypes as markers for susceptibility to lung cancer, Nature, 312, 169-170
  7. Perera, F. P., 1997, Environment and cancer: who are susceptible?, Science, 278, 1068-1073
  8. Raunio, H., K. Husgafvel-Pursiainen, S. Snttila, S. Anittila, E. Hietanen and A. Hirvonnen, 1995, Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility-a review, Gene, 159, 113-121
  9. Kim, H., Y. D. Kim, C. H. Lee, T. Kawamoto, M. Yang and T. Katoh, 1999, Assay of 2-naphthol in human urine by high-performance liquid chromatography, J. Chromatogr. B., 734(2), 211-217
  10. Kristensen, V. N., T I. Andersen, B. Erikstein, G. Feitvik, E. Skovlund, J. M. Nesland and A. L. Brorrensen-Dale, 1998, Single tube multiplex polymerase chain reaction genotype analysis of GSTM1, GSIT1 and GSTP1, Pharmacogenetics, 8, 441-447
  11. Deguchi, T, 1992, Sequence and expression of alleles of polymorphic arylamine N-acetyltransferase of human liver, J. BioI. Chem., 267, 8-40
  12. Ketterer, B., 1988, Protective role of glutathione and glutathione transferases in mutagenesis and carcinogenesis, Mutat. Res., 202, 343-361
  13. 김헌, 김승택, 오태근, 1998, 한국인의 ACE, TNF-${\beta}$, APOE, VDR, EDH17B2, CYP1A1, GSTM1, GSTT1, NAT2 그리고 ALDH2 유전자 유형 분포에 대한 조사연구, 보건복지부 최종보고서
  14. Pemble, S., K. R. Schroeder, S. R. Spencer, D. J. Meyer, E. Hallier and H. M. Bolt, 1994, Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism, Biochem. J., 399, 271-276
  15. 김대선, 김정현, 박재성, 강택신, 유승도, 차정훈, 안승철, 나진균, 황승률, 2003, 유해화학물질의 노출 및 영양지표분석기술에 관한 연구(II): PAHs를 중심으로, 국립환경연구원보, 25, 47-60
  16. Warholm, M., A. Alexandrie, J. Hgberg, K. Sigvardsson and A. Rannug, 1994, Polymorphic distribution of glutathione transferase activity with methylchloride in human blood, Pharmacogenetics, 40, 307-311
  17. Ichiba, M., L. Hagmar and A. Rannug, 1994, Aromatic DNA adducts, micronuclei and genetic polymorphism for CYP1A1 and GSTM1 in chimney sweeps, Carcinogenesis, 15, 1347-1352
  18. Hein, D. W., M. A. Doll, T. D. Rustan and R. J. Fergoson, 1995, Metabolic activation of N-hydroxyarylamines and N-hydroxyarylamides by 16 recombinant human NAT2 allozymes: effects of 7 specific NAT2 nucleic acid substitutions, Cancer Res., 55, 3531-3536
  19. 김 헌, 김원재, 이형래, 이무송, 김철환, 김로사, 남홍매, 1998, N-acetyltransferase2와 glutathione S-transferase mu 및 theta 다형성이 방광암 발생에 미치는 영향에 대한 환자-대조군 연구, 예방의학회지, 31(2), 275-284
  20. Scales, M. D. and J. A. Timbrell, 1982, Studies on hydrazine hepatotoxicity: 1. Pathological findings, J. Toxicol. Environ. Health, 10, 941-953
  21. Nakaki, K., K. Imai, S. I. Hayashi and K. Kawajiri, 1993, Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population, Cancer Res., 53, 2994-2999
  22. Yang, M., M. Koga, T. Katoh and T. Kawamoto, 1999, A study for the proper application of urinary naphthols, new biomarker for airbone polycyclic aromatic hydrocarbons, Arch. Environ. Cantam. Toxicol., 36(1), 99-108
  23. 이지나, 임종환, 박신구, 신주연, 이관희, 홍윤철, 김 헌, 이철호, 2004, 흡연과 주거환경이 요중 2-naphthol 농도에 미치는 영향, 대한산업의학회지, 16(1), 82-91
  24. 강종원, 조수헌, 김헌, 강대희, 이철호, 2000, 일반 인구집단에 대한 대기중 총먼지의 생물학적 노출지표로서 요중 1-hydroxypyrene 및 2-naphthol의 유용성, 예방의학회지, 33(3), 306-312
  25. Kim, H., J. W. Kang, S. H. Cho, Y. D. Kim, H. M. Nam, C. H. Lee and T. Kawamoto, 2001, Urinary 1-hydroxypyrene and 2-naphthol concentrations in male Korea, Int. Arch. Occup. Environ. Health, 74, 59-62
  26. 이효민, 윤은경, 박경아, 김윤희, 정소영, 전기성, 김명철, 송인상, 이철호, 양지선, 양기화, 2003, 식품 중 Polycyclic Aromatic Hydrocarbons의 위해성 평가, 한국식품위생안전성학회, 19(1), 1-8
  27. Chen, H., D. P. Sandler, J. A. Taylor, D. L. Shore, E. Liu, C. D. Bloornfield and D. A. Bell, 1996, Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1(GSTT1) gene defect, Lancet, 347, 295-297
  28. Gabbani, G., S. M. Hou, B. Nardini, M. Marchioro, B. Lambert and E. Clonfero, 1996, GSTM1 and NAT2 genotypes and urinary metabolites in coke oven workers, Carcinogenesis, 17, 1677-1681
  29. Wu, M. T., K. T. Kelsey, I. F. Mao, D. Wypij and H. W. Liu, 1997, Elevated serum liver enzymes in coke oven and by-product workers, J. Occup. Environ. Med., 39(6), 527-533
  30. Menzie, C. A., 1992, Ambient concentrations and exposure to carcinogenic PAHs in the environment, Environmental Science and Technology, 26(7), 1278-1284
  31. Jongeneelen, F. J., R. B. M. Anzion and P. T. Henderson, 1987, Detection of hydroxylated metabolites of polycyclic aromatic hydrocarbons in urine, J. Chromatogr., 413, 227-232
  32. 이송권, 남철현, 노병의, 이영세, 조기현, 1997, 요중 1-OH-pyrene을 이용한 PAH환경근로자들의 노출평가 및 위생조치에 의한 총 노출량 감소효과, 한국산업위생학회지, 7(2), 264-278